Ubs Group Ag Catalyst Biosciences, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$0.33 - $0.65 $6,898 - $13,587
-20,904 Reduced 80.45%
5,079 $2,000
Q2 2023

Aug 11, 2023
BUY
$0.2 - $0.35 $5,196 - $9,094
25,983 New
25,983 $9,000
Q2 2022

Aug 10, 2022
BUY
$0.36 - $1.78 $2,765 - $13,673
7,682 New
7,682 $14,000
Q1 2022

May 16, 2022
SELL
$0.51 - $1.0 $2,654 - $5,205
-5,205 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.91 - $4.16 $4,736 - $21,652
5,205 New
5,205 $5,000
Q3 2021

Nov 15, 2021
SELL
$3.78 - $5.18 $9,862 - $13,514
-2,609 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$4.1 - $5.33 $22,262 - $28,941
-5,430 Reduced 67.55%
2,609 $11,000
Q1 2021

May 12, 2021
BUY
$4.93 - $7.15 $10,683 - $15,494
2,167 Added 36.9%
8,039 $41,000
Q4 2020

Feb 11, 2021
BUY
$4.55 - $7.29 $24,269 - $38,884
5,334 Added 991.45%
5,872 $37,000
Q3 2020

Nov 12, 2020
SELL
$4.22 - $6.04 $675,735 - $967,167
-160,127 Reduced 99.67%
538 $2,000
Q2 2020

Jul 31, 2020
BUY
$3.76 - $8.01 $600,017 - $1.28 Million
159,579 Added 14694.2%
160,665 $944,000
Q1 2020

May 01, 2020
SELL
$3.5 - $8.51 $9,590 - $23,317
-2,740 Reduced 71.62%
1,086 $4,000
Q4 2019

Feb 14, 2020
BUY
$4.52 - $7.91 $9,482 - $16,595
2,098 Added 121.41%
3,826 $26,000
Q3 2019

Nov 14, 2019
BUY
$4.91 - $9.31 $7,924 - $15,026
1,614 Added 1415.79%
1,728 $8,000
Q2 2019

Aug 14, 2019
SELL
$7.08 - $10.6 $16,772 - $25,111
-2,369 Reduced 95.41%
114 $1,000
Q1 2019

May 14, 2019
SELL
$7.67 - $9.96 $56,405 - $73,245
-7,354 Reduced 74.76%
2,483 $20,000
Q4 2018

Feb 14, 2019
BUY
$6.59 - $11.28 $8,507 - $14,562
1,291 Added 15.11%
9,837 $78,000
Q3 2018

Nov 14, 2018
BUY
$9.35 - $12.44 $17,409 - $23,163
1,862 Added 27.86%
8,546 $92,000
Q2 2018

Aug 14, 2018
BUY
$9.11 - $28.88 $49,030 - $155,432
5,382 Added 413.36%
6,684 $78,000
Q1 2018

May 15, 2018
SELL
$14.18 - $35.6 $332,450 - $834,642
-23,445 Reduced 94.74%
1,302 $34,000
Q4 2017

Feb 14, 2018
BUY
$4.52 - $13.69 $1,817 - $5,503
402 Added 1.65%
24,747 $338,000
Q3 2017

Nov 14, 2017
SELL
$3.19 - $5.1 $5,818 - $9,302
-1,824 Reduced 6.97%
24,345 $123,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,824 Added 7.49%
26,169 $122,000
Q1 2017

Nov 14, 2017
BUY
N/A
24,345
24,345 $230,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email